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ABSTRACT: Mutations in the OPN1LW (L-) and
OPN1MW (M-)cone opsin genes underlie a spectrum of
cone photoreceptor defects from stationary loss of color
vision to progressive retinal degeneration. Genotypes of
22 families with a range of cone disorders were grouped
into three classes: deletions of the locus control region
(LCR); missense mutation (p.Cys203Arg) in an L-/M-
hybrid gene; and exon 3 single-nucleotide polymorphism
(SNP) interchange haplotypes in an otherwise normal
gene array. Moderate-to-high myopia was observed in all
mutation categories. Individuals with LCR deletions or
p.Cys203Arg mutations were more likely to have nystag-
mus and poor vision, with disease progression in some
p.Cys203Arg patients. Three disease-associated exon 3
SNP haplotypes encoding LIAVA, LVAVA, or MIAVA
were identified in our cohort. These patients were less
likely to have nystagmus but more likely to show pro-
gression, with all patients over the age of 40 years having
marked macular abnormalities. Previously, the haplotype
LIAVAhas been shown to result in exon 3 skipping. Here,
we show that haplotypes LVAVA and MIAVA also result
in aberrant splicing, with a residual low level of correctly
spliced cone opsin. TheOPN1LW/OPN1MW:c.532A>G
SNP, common to all three disease-associated haplotypes,
appears to be principally responsible for this mutational
mechanism.
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Introduction
Mutations in the long-(L-) (OPN1LW; MIM #300822) and
medium-(M-) (OPN1MW; MIM #300821) wavelength-sensitive
cone opsin genes on Xq28 [Nathans et al., 1986a, 1989; Neitz and
Neitz, 2011] result in a number of cone photoreceptor disorders, in-
cluding red-green color blindness (MIM #303900, MIM #303800),
X-linked cone dysfunction (MIM #300843), X-linked cone dys-
trophy (COD5; MIM #303700), and blue cone monochromatism
(BCM; MIM #303700) [Nathans et al., 1986a,b, 1989; Winderickx
et al., 1992; Jagla et al., 2002; Crognale et al., 2004; Kellner et al.,
2004; Neitz et al., 2004; Young et al., 2004; Michaelides et al., 2005a;
Gardner et al., 2009; Gardner et al., 2010; Mizrahi-Meissonnier
et al., 2010]. The majority of subjects with an L- and M-opsin
disorder are thought to have a stable condition; however, some de-
velop evidence of progression with increasing visual acuity loss,
macular atrophy, retinal pigmentation, and electrophysiological ev-
idence of S-cone and rod involvement. It thereby appears that some
sequence alterations in the cone opsin genes can result in photore-
ceptor degeneration [Fleischman and O’Donnell, 1981; Nathans
et al., 1989; Ayyagari et al., 1999; Michaelides et al., 2005b; Gardner
et al., 2009; Gardner et al., 2010]. Recently, high-resolution reti-
nal imaging in subjects with L- and M-opsin mutations suggested
that phenotypic variation may be a result of subsets of mutations
displaying distinct visual and cellular phenotypes [Carroll et al.,
2009, 2010, 2012].
The L- and M-genes in a wild-type array lie in tandem, with a
single L-gene upstream of one or more M-genes [Nathans et al.,
1986a; Vollrath et al., 1988] with only the first two genes in the array
thought to be expressed, owing to their proximity to an upstream
cis-regulatory locus control region (LCR; MIM #300824) [Nathans
et al., 1989; Wang et al., 1992]. The nucleotide composition of the
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first two genes within the array dictates the opsins expressed in L-
andM-cone photoreceptors. The L- andM-opsin genes derive from
a single opsin ancestor and retain a high-sequence homology of
their coding sequences, introns, and downstream regions [Nathans,
1999]. The sequence similarity and their genetic head-to-tail ar-
rangement results in frequent nonhomologous inter- and intragenic
recombination (NHR) and gene conversion events [Hayashi et al.,
1999]. As a result, whole genes are frequently deleted, gained, or
rearranged to form hybrid L-/M- or M-/L-genes [Deeb et al., 1992;
Neitz and Neitz, 2011]. Genetic rearrangement also forms combi-
nations of polymorphic L- and M-variants that alter the spectral
properties of the encoded proteins and lead to a range of normal or
color vision deficient phenotypes [Neitz and Neitz, 2011].
BCM is a severe condition in which neither L- nor M-cones are
fully functional. The genetic mechanism of BCM is thought to fol-
low a number of pathways: one involves a single-step process in
which an LCR deletion prevents expression of the genes in the array
[Nathans et al., 1989; Wang et al., 1999; Smallwood et al., 2002].
Another involves a two-step process in which NHR reduces the
number of cone opsin genes in the array to one, before a second
event (mutation) inactivates the remaining gene [Nathans et al.,
1993]. Reported inactivating mutations include missense and non-
sense mutations and partial coding sequence deletions [Nathans
et al., 1989; Ladekjaer-Mikkelsen et al., 1996; Wang et al., 1999;
Ayyagari et al., 2000; Michaelides et al., 2005b; Gardner et al., 2009;
Mizrahi-Meissonnier et al., 2010]. A further, less common mecha-
nism involves inactivation of the first two genes of the array by a
mutation that is transferred from one gene to another by means of
NHRor gene conversion [Reyniers et al., 1995; Gardner et al., 2010].
More recently, an additional category of mutants has been identi-
fied that displays an unusual genetic mechanism. This category of
ancestral interchange haplotypes has been identified as a signifi-
cant cause of both red/green dichromacy and BCM [Carroll et al.,
2004; Crognale et al., 2004; Neitz et al., 2004]. Interchange haplo-
types arise as a result of recombinations between L- and M-opsin
genes that create unusual, and potentially deleterious, combinations
of exon 3 single-nucleotide polymorphisms (SNPs). In isolation,
these SNPs would not be considered detrimental to gene function.
Oneexample is thedeleteriousSNPhaplotypeOPN1LW/OPN1MW:
c.[ 457G; 511A; 513T; 521C; 532G; 538G] that encodes p.[Leu153;
Ile171;Ala174:Val178;Ala180] or p.[L;I;A;V;A] for ease of reference.
Functional analyses of different cone opsin mutations suggest
they may have different disease mechanisms and associated reti-
nal phenotypes [Carroll et al., 2010; Gardner et al., 2010; Ueyama
et al., 2012; Cideciyan et al., 2013]. Deletion of the LCR has been
shown to result in a complete lack of expression of cone opsin,
morphological changes to the cone outer segments, and to reduced
cone density and disrupted organization of the cone mosaic [Car-
roll et al., 2010; Cideciyan et al., 2013]. In contrast, the missense
mutations, p.Cys203Arg (p.C203R) and p.Trp177Arg (p.W177R),
encode cone opsins that are misfolded and retained in the endo-
plasmic reticulum. These misfolded mutant cone opsins would be
expected to be degraded leading to loss of cone opsin function and
potentially might be toxic to photoreceptors, similar to misfolding
mutations in rhodospin, leading to a potentially progressive cone
dystrophy phenotype [Kazmi et al., 1997; Gardner et al., 2010; Car-
roll et al., 2012]. Interestingly, the disease-associated interchange
SNP haplotype LIAVA has recently been shown to cause aberrant
splicing in vitro, with skipping of exon 3. This mutational mecha-
nism is predicted to result in a frameshift and a nonfunctional cone
opsin [Ueyama et al., 2012].
In this study, we present detailed genetic and phenotypic analysis
of a cohort of 26 affected males from 22 families with a range of
phenotypes, from BCM to X-linked cone dystrophy, and describe
correlations between the genetic mechanism of disease and clinical
outcome.
Material and Methods
Subjects and Clinical Assessment
Male probands and participating relatives from 22 families with
BCM, X-linked cone dysfunction syndrome, or X-linked cone dys-
trophy were recruited. If possible, individuals were examined more
than twice over a period of 5 years or longer, allowing longitu-
dinal evaluation of the phenotype. Written informed consent was
obtained from all subjects and the study was conducted according
to the tenets of the Declaration of Helsinki. Ethical approval for
the study was provided by Moorfields Eye Hospital, London, the
Women’s and Children’s Hospital, North Adelaide, and the Royal
Victorian Eye and Ear Hospital, Melbourne.
Clinical assessment includedmedical history, family history, best-
corrected Snellen visual acuity, refraction, slit-lamp biomicroscopy,
dilated fundus examination, and digital fundus photography (TRC-
501A; Topcon, Tokyo, Japan). Color vision was tested using Hardy–
Rand–Rittler pseudo-isochromatic plates. Myopia was character-
ized as low (<3 diopters), moderate (3–6 diopters inclusive), or
high (>6 diopters). Fundus autofluorescence (FAF) imaging and
spectral domain optical coherence tomography (SD-OCT) imaging
was performed where possible. The Spectralis HRA and OCT with
viewing module version 5.1.2.0 (Heidelberg Engineering, Heidel-
berg, Germany) was used to obtain FAF and SD-OCT images and
the HEYEX software interface (version 1.6.2.0; Heidelberg Engi-
neering) was used to view images.
Electrophysiological assessment at Moorfields Eye Hospital in-
cluded full field ERG and pattern ERG (PERG), recorded using gold
foil corneal recording electrodes in 10 patients, incorporating the
standards of the International Society for Clinical Electrophysiology
of Vision (ISCEV) [Holder et al., 2007; Marmor et al., 2009; Bach
et al., 2013]. Adark-adapted brighter flashERG, as recommendedby
ISCEV, was additionally recorded to a flash strength of 11.0 cd s m–2
better to identify photoreceptor function. These patients also had
scotopic red flash ERG testing, used to assess the relative contri-
butions of dark-adapted cone and rod systems. Short-wavelength
flash ERGs were performed using a blue stimulus (5 msec duration,
445 nm, 80 cd m–2) on an orange background (620 nm, 560 cd m–2)
[Arden et al., 1999; Bach et al., 2013]. Full-field ERG measures of
dysfunctionwere defined as:mild (70%–99%of normal amplitude),
moderate (30%–69% of normal), severe (1%–29% of normal), or
undetectable. Two subjects had repeat ERGs after 5 or 12 years to
determine ERG progression. The ERGs in an additional nine chil-
drenwere performedwith surface electrodes according to shortened
pediatric protocols [Holder and Robson, 2006] that were sufficient
to help establish the diagnosis.
Genomic Sequencing of the Cone Opsin Array
Genomic DNA was extracted from EDTA blood samples. The
structural integrity of the L-/M-opsin gene array on Xq28 was in-
vestigated in several stages. Initially, all six coding exons andflanking
intronic boundaries ofOPN1LW andOPN1MW, and noncoding re-
gions, including the 37-bp core sequence of the upstream LCR and
the upstream and downstream promoters, were analyzed by direct
sequencing of PCR amplicons, as described previously [Gardner
et al., 2009]. The opsin cDNAs are numbered according to Ensembl
Transcripts ENST00000369951 (OPN1LW) and ENST00000147380
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(OPN1MW). cDNAnucleotide numberinguses +1 as theATG trans-
lation initiation codon in the reference sequence, with the initiation
codon as codon 1. PCR products were purified with ExoSAP-IT (GE
Healthcare,Amersham,UK)andSanger sequenced (AppliedBiosys-
tems, Warrington, UK) as described previously [Gardner et al.,
2009]. Sequence data were examined with Lasergene DNA Star soft-
ware (DNA STAR, Inc.Madison,WI). Sequence changes were tested
for segregation with the condition in participating relatives.
Long-Range PCR to Determine Multigene Array Sequence
and Structure
The exon structure of all intact genes including L-genes,M-genes,
L-/M-, or M-/L-hybrid genes in each multigene array was deter-
mined by long-range PCR amplification of L-class genes (contain-
ing an L-type exon 5) and M-class genes (containing an M-type
exon 5), followed by second round PCR amplification of exons 2,
3, and 4, using methods described previously [Neitz et al., 2004].
In cases where an unusual SNP haplotype was present in an L-class
gene (comprising L-type exons 2–5), but not in any M-class genes,
the position of L-class genes bearing the SNP haplotype was deter-
mined by testing whether the mutant L-gene was present in an up-
stream location, downstream location, or both. This was achieved
by pairing a forward primer specific to the upstream promoter
(UPF: CCTGGGCTTTCAAGAGAACCACATG) with an L-specific
exon 2 reverse primer (LE2R; CCCAGCACGAAGTAGCCAG) and
in a separate reaction, pairing LE2Rwith a forward primer upstream
of OPN1LW and OPN1MW (LM1F; GGTGGGAGGAGGAGGTC-
TAA). The products were then sequenced to determine the presence
of upstream and downstream sequence variants 5′ to exon 1. When
an exon 3 mutant haplotype was present in a multigene array in
more than one L-gene, and the array also had an M-gene with a
normal exon 3 haplotype, it was concluded that in order for an L-
and M-opsin deficient phenotype to occur, the L genes bearing the
mutant haplotypes occupied the first two positions in the array.
LCR Deletions
In subjects in whom no amplification of the LCR-core se-
quence was achieved, a possible LCR deletion was suspected. Three
sequence-tagged sites (STSs), located at intervals 7.5, 8.4, and 9.3 kb
upstream of the L-gene transcription initiation site, were then am-
plified to determine the approximate upstream extent of the dele-
tion, as described previously [Carroll et al., 2010]. If no product was
obtained for the STSs, the first exons of the genes flanking the opsin
array, MECP2 and TKTL, were amplified to evaluate the extent of
the deletion (primer sequences available on request).
In Vitro Splicing Assay
Wild-type (color normal) or interchange OPN1LW (L-) and
OPN1MW (M-) genomic sequence clones in pFLAGCMV-5a (mini-
genes), spanning exon 2–4, were described previously [Ueyama
et al., 2012]. Five cone opsinminigenes were investigated in the cur-
rent study: two with SNP haplotypes encoding color-normal opsins
LVAIS orMVAIA, and three encoding the proposed deleterious hap-
lotypes LIAVA, LVAVA, or MIAVA. The c.457C>A (p.Leu153Met)
variant of theMIAVAhaplotype was introduced into the L-opsin LI-
AVAminigene by site-directed mutagenesis using the QuickChange
Lightning Site-Directed Mutagenesis Kit (Stratagene, Agilent, UK)
in accordance with the manufacturer’s protocol (primer sequences
available on request). The variant c.532A>G (p.Ile178Val) was
investigated in isolation and introduced within the color-normal
haplotype minigenes LVAIS or MVAIA using the same protocol.
XL10-Gold ultracompetent cells (Agilent Technologies,Waldbronn,
Germany) were transformed with 20 ng of minigene DNA and
plasmid DNAwas isolated using a QuickLyseMiniprep kit (Qiagen,
Crawley, UK). All constructs were sequenced to ensure fidelity and
orientation.
HEK293 cells were transfected with 500 ng of wild-type or mu-
tant minigenes using Lipofectamine (Life Technologies Ltd, Paisley,
UK). After 24 hr incubation, cells were harvested and lysed us-
ing 600 μl lysis buffer. Total RNA was extracted using an RNeasy
mini kit (Qiagen, Crawley, UK) with on-column DNAse treatment
(Promega, Hampshire, UK), according to the manufacturer’s in-
structions. cDNA was synthesized from approximately 1 μg to-
tal RNA using a Tetro cDNA Synthesis Kit (Bioline Reagents Ltd,
London, UK) with TetroRTase enzyme and Anchored Oligo (dT)
primers in accordance with the manufacture’s guidelines. Vector-
specific primers were used to establish cDNA linearity loading con-
trols for the experimental PCR assays [Ueyama et al., 2012]. The
products were analyzed on a 2% agarose gel and either sequenced
directly, or gel extracted using a QIAquick
R©
gel extraction kit (Qi-
agen) and cloned into pGEM
R©
-T Easy Vector System (Promega)
prior to sequencing. Plasmid DNA was extracted using the GenE-
lute Plasmid Miniprep Kit (Sigma–Aldrich Company Ltd., Dorset,
UK), followed by sequencing using the Big Dye Terminator v3.1
Cycle Sequencing reagents as recommended by the manufacturer
(Applied Biosystems).
Databases and Bioinformatics
Ensemble and UCSC Genome Browsers were used for analyses
of the Human Feb 2009 (GRCh37/hg19) Assembly. In silico splic-
ing analyses were performed using pre-mRNA splicing prediction
programs RESCUE-ESE [Fairbrother et al., 2002; Fairbrother et al.,
2004] and FAS-ESS [Wang et al., 2004]. Candidate exonic splicing
enhancer (ESE) sequences in exon 3 of the opsin gene haplotypes
were identified using the human ESE parameter of RESCUE-ESE
(http://genes.mit.edu/burgelab/rescue-ese/). The FAS-hex2 set of
FAS-ESS (http://genes.mit.edu/fas-ess/) enabled detection of can-
didate exon splice silencer motifs in each exon 3 haplotype.
Statistical Analysis
The relationshipbetweenflickerERGamplitudes (corneal record-
ings) and patient age was examined in the interchange haplotype
group by linear regression and a correlation coefficient was deter-
mined using Microsoft Excel. The coefficient of variation (r2) was
derived from the linear regression through six data points. A P value
was obtained using a table of critical values of the t-distribution for
n-2 degrees of freedom.
Results
Clinical data for 26 affectedmales from 22 different families, with
an age range of 4–80 years, are summarized in Supp. Table S1. All
pedigrees are illustrated in Fig. 1, with the exception of Family 22,
which is shown in Supp. Figure S1. For ease of interpretation, clinical
and genetic detail of individuals within these pedigrees have been
assigned subject numbers (S1–S26) and are annotated on Figs. 1
and 2, Supp. Figure S1, Supp. Table S1, and all clinical figures.
A diagrammatical representation of the cone opsin gene array
structure in each family is shown in Fig. 2, classified into three
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Figure 1. Pedigree structure and subject IDs of families and patients recruited to this study. Filled box represents affected male. F1–20 refers to
Family ID. S refers to subject number in clinical table, figures, and description in text.
distinct mutation categories: (1) deletion of the LCR (five fami-
lies), (2) single hybrid gene with inactivating missense mutation
c.607T>C (p.Cys203Arg) (eight families), and (3) SNP interchange
haplotypes (nine families).
All subjects, with the exception of subject S26, reported onset of
symptoms in their first decade of lifewith impaired color and central
vision being the main symptoms. S26 reported normal vision until
his late 20s, when he noticed reduced central vision. All patients
were ametropic, most commonly myopic.
Deletion of the LCR and Associated Phenotypes
Deletions of the LCR were identified in five unrelated male
probands (S1–S5) (Figs. 1 and 2; Supp. Table S1). The deletion
in S4 involved the LCR-core sequence and the first upstream STS
(7.5 kb) but not the upstream promoter or coding regions of the ar-
ray. Three probands (S1, S2, and S5) had deletions of the LCR-core
region that extended upstream to include the first and second STSs
(7.5 and 8.4 kb) and downstream into the coding sequence of the
proximal L-gene (Fig. 2). Genomic DNA of S3 did not amplify for
regulatory regions, STSs, or cone opsin exons, which indicated the
presence of an extensive deletion involving the entire opsin array.
The first exons of the two genes flanking the opsin array, MECP
and TKTL, were successfully amplified in this individual, indicating
these genes were not deleted (Fig. 2).
The five probands with LCR deletions had ages ranging from
10–58 years and had onset in early infancy. All five had low to
high myopia with reduced central visual acuity ranging from 6/30
to 6/60 (Supp. Table S1). Four out of five subjects (S1–S4, aged
10–17 years) had nystagmus, whereas S5 (age 58 years), who was
first seen in adulthood in his late 40s, did not have documented
nystagmus. Fundus examination revealed myopic fundi. Macular
SD-OCT showed disruption of the inner segment ellipsoid (ISe)
layer to a greater extent in S5 (age 58 years) compared with S2
(age 14). Follow-up of these subjects from 2–8 years showed no
evidence of clinical progression. Figure 3 shows the myopic fun-
dus photograph, abnormal central FAF, and disrupted ISe SD-OCT
image of S5. Two children underwent ERG testing with surface elec-
trodes (S1 and S3) and two subjects (S2 and S5) underwent ERGs at
the ages of 10 and 51 years (Supp. Tables S2 and S3 and Supp. Figs.
S2–S4). All had undetectable or severely abnormal flicker and/or
photopic ERGs consistent with severe generalized cone system dys-
function. All four also had undetectable PERGs, consistent with
severe macular dysfunction. Scotopic ERG showed mild rod system
involvement in S2 only, with a preserved S-cone ERG.
Hybrid Genes with an Inactivating p.Cys203Arg Missense
Mutation and Associated Phenotypes
A hemizygous c.607T>C, p.Cys203Arg missense mutation
(Fig. 2) was identified in eight probands (S6–S12 and S13), and
two affected relatives of S13 in Family 22 (S14 and S15) (Fig. 1;
Supp. Fig. S1). Each subject had a single L-/M-hybrid gene sequence
with the inactivating p.Cys203Arg missense mutation in exon 4. No
wild-type cone opsin exon 4 sequence was identified.
In Family 22, the proband S13 (IV-1) aged 27 years, his affected
half-brother S14 (IV-3), and nephew S15 (V-2) were diagnosed
with “X-linked cone dystrophy” (Supp. Fig. S1). S13 had a bull’s-eye
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Figure 2. Diagrammatical representation of L- and M-cone opsin array genotypes. Subject number is shown to the left of each array. The L- and
M-wild-type opsin array is composed of OPN1LW (exons 1–6 depicted by black boxes) and OPN1MW genes (exons 1–6 depicted by gray boxes)
lying in tandem. Transcription is controlled by an upstream LCR (black circle) and an upstream (black oval) and downstream (gray oval) promoter.
Deletion of the LCR and upstream STSs are depicted by an X. Flanking genes MECP and TKTL are shown in black boxes in a 5′ and 3′ position to
the array. Missense mutations and exon 3 haplotypes are shown above the relevant exon.
maculopathy that had been noted from the age of 10 years. All
three affected subjects hadmacular pigmentation that had been vis-
ible from early childhood. Interestingly, the maternal grandfather
(III-4) and two half-brothers (V-1 and V-3) of the youngest affected
individual S15 (V-2) had red/green color blindness but had no sig-
nificant loss of visual acuity, myopia, or nystagmus (Supp. Fig. S1).
Unusually, the mother of S15 (IV-7) also had red/green color blind-
ness. Analysis of the opsin gene array in this family showed segre-
gation of two different opsin genotypes with the two different phe-
notypes (Supp. Fig. S1). The three affected visually impaired males
(Supp. Table S1; patients S13–S15) had a single L-/M-hybrid gene
with the inactivating p.Cys203Arg mutation, inherited from their
respectivemothers (Supp. Fig. S1). The half-brothers (V-1 and V-3)
with red/green color blindness had a cone opsin array comprising
only a single functional M-gene accounting for the color vision de-
ficiency (protanopia). Their color blindmother (IV-7) was a carrier
of the single hybrid mutant p.Cys203Arg on one X-chromosome,
and a single M-gene on the other (inherited from her father; Supp.
Fig. S1).
Individuals in the study with this mutation class had onset in
early infancy. The age range of affected individuals was 4–27 years
with visual acuity ranging from 6/19 to 3/60. Nine of 10 subjects
had documented nystagmus and all had low-to-moderate myopia
or myopic astigmatism. S11 (age 16 years) had some peripheral
hyperpigmentation, and S13 and S15 from Family 22 (age 27 and
19 years) had macular atrophy, but fundus examination was unre-
markable in the remaining patients. SD-OCT for S10 (age 14 years)
revealed mild granular disruption of the ISe layer at the macula,
but was unremarkable in the remaining three individuals that were
imaged. Fundus photographs, FAF, and SD-OCT images of S12
(normal imaging) are shown in Fig. 3. In two young patients with
high myopia (S10 and S12), photopic ERGs were consistent with
severe generalized cone system dysfunction (Supp. Tables S2 and
S3; Supp. Figs. S2–S4). The S-cone ERGs were preserved in S10 (ex-
cluded in S12 due to eye movement artifact). Scotopic ERGs were
normal (S10) or mildly abnormal (S12). There was PERG evidence
of severe macular dysfunction in S10 and S8, andmoderate macular
dysfunction in S12 (the only patient in the entire cohort to have a
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Figure 3. Examples of clinical findings on imaging. Color fundus photographs, FAF, and SD-OCT images of patients with LCR deletion (S5),
p.Cys203Arg missense mutation (S12) and exon 3 interchange haplotypes (S17–S26). S17, aged 18 years, had normal fundus imaging, whereas all
the other exon 3 haplotype patients who were aged40 years (S19–21, S23, and S26) showed evidence of macular abnormalities on one or more
imaging modalities. Supp. Table S1 provides further phenotypic details.
detectable PERG P50 component). Two subjects (S13 and S10) were
followed up for 7 and 10 years, respectively, with no definite clinical
evidence of progression.
Disease-Causing SNP Interchange Haplotypes and
Associated Phenotypes
Nineprobands (S16–21, S23, S24, andS26)hadL-/M-interchange
genotypes (Supp. Table S1; Figs. 1 and 2). For ease of reference and
consistency with the literature, genotypes are referred to by their
exon 3 protein coding haplotype (Table 1). Analysis of these gene
arrays revealed the presence of two or more genes with a deleterious
haplotype associated with an upstream or downstream promoter
(Fig. 2).
Four individuals (S18, S19, S20, and S21) had arrays comprising
only an L- or L-/M-hybrid gene with an interchange haplotype
in exon 3 of either LIAVA (S21) or LVAVA (S18, S19, and S20)
(Fig. 2). Five subjects (S16, S17, and S24–S26) had multigene arrays
that included at least one gene with a rare interchange haplotype
and at least one (M-)gene with an MVVVA haplotype. Two of these
subjects (S16 and S17) had an LIAVA haplotype and one (S26)
had an LVAVA haplotype. The two remaining related subjects (S22
and S23) with multigene arrays had genes encoding LIAVA and
MIAVA. The interchange haplotypes in these families segregated
with the condition (Supp.Table S1; Figs. 1 and2). These data identify
interchange haplotypes as a relatively common cause of disease in
our cohort.
Subjects S16–26 harbored exon 3 SNP interchange haplotypes
(Fig. 2) and hadmoderate-to-highmyopia (>6 diopters), except S23
and S26 who had low myopia (<3 diopters). Onset of disease was
in infancy, apart from S26 who presented in his early 20s. A greater
degree of phenotypic heterogeneity was observed in this mutation
class compared with the LCR deletion and inactivated single gene
array classes. Visual acuity ranged from6/12 in the younger subjects,
to 6/60 in S21 and S23, who were aged 73 and 68 years, respectively.
Three subjects out of eleven (S22–S24) had documented nystag-
mus. Fundus findings appeared to be related to patient age, with
younger patients (<40 years, S16–S18, S22, and S24) showing only
myopic changes or mild pigmentary abnormalities (Fig. 3), whereas
all older patients (40 years), except S25, had evidence of macu-
lar abnormalities on examination, photography, FAF, or SD-OCT.
Subject S19 (age 40 years; Fig. 3) had central outer retinal atrophy
on photography and SD-OCT; subject S20 (age 49 years; Fig. 3) had
subfoveal lucencies on SD-OCT; S21 (age 73 years; Fig. 3) had bi-
lateral bull’s-eye macular lesions and atrophy on FAF and SD-OCT;
S23 (age 68 years; Fig. 3) also had bilateral bull’s-eye lesions on FAF;
and S26 (age 80 years; Fig. 3) had disruption of the outer retinal lay-
ers on SD-OCT. Subject S25 (age 51 years) was the only patient over
the age of 40 years in this group with exon 3 SNP interchange haplo-
types who did not have documented macular abnormalities, but he
did not have FAF or SD-OCT imaging performed. ERGs performed
>20 years ago in this patient showed severe cone and rod system
dysfunction. In the six patients with L-/M-interchange genotypes
for whom electrophysiology was performed, there was moderate-
to-severe photopic flicker ERG reduction (Supp. Figs. S2–S5).
There was a trend for ERG amplitudes (corrected for age) to de-
crease with increasing age (Supp. Fig. S4). S-cone ERG amplitudes
were normal in all but one subject (S23; age 63 years). Scotopic red
flash ERGs revealed no detectable dark-adapted cone system func-
tion in any patient (Supp. Fig. S2) and PERGs were undetectable
in six of six cases. Scotopic ERGs were normal (S16–S18, S21, and
S23) or had some mildly (S20 and S22) or moderately (S19 and
S25) abnormal parameters (Supp. Figs. S2 and S3). The oldest pa-
tient (S26; 69 years at the time of first ERG) showed evidence of
marked reduction in scotopic ERGs when tested 5 years later (Supp.
Fig. S5); patient 21 (59 years at time of ERG) showed an increase
in rod (DA 0.01) ERG timing by 15 msec after 12 years (Supp.
Fig. S5).
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Table 1. Genotype of Wild-Type and Interchange SNP Haplotypes Associated with Disease in Exon 3 of the L- and M-Opsin Genes with
Corresponding Consequence on Opsin Transcript and Any Resulting Protein
Exon 3 haplotype
(translated)
Expected opsin
function DNA variant position and corresponding amino acid Opsin transcript(s)
Predicted effect on
protein
c.453
p.151
c.457
p.153
c.465
p.155
c.511
p.171
c.513
p.171
c.521
p.174
c.532
p.178
c.538
p.180
LVAIS Normal G C
Leu
G G
Val
G C
Ala
A
Ile
T
Ser
r.[ = ] p.[ = ]
MVAIA Normal A A
Met
C G
Val
G C
Ala
A
Ile
G
Ala
r.[ = ] p.[ = ]
LIAVA Affected G C
Leu
G A
Ile
T C
Ala
G
Val
G
Ala
r.[410 578del] p.{Ile138Thrfs∗6}
LVAVA Affected G C
Leu
G G
Val
G C
Ala
G
Val
G
Ala
r.[ = , 410 578del,
350 578delins579–
127 579–1]
p.{ = , Ile138Thrfs∗6,
Tyr118Serfs∗5}
MIAVA Affected A A
Met
C/G A
Ile
T C
Ala
G
Val
G
Ala
r.[ = , 410 578del,
350 578delins579–
127 579–1]
p.{ = , Ile138Thrfs∗6,
Tyr118Serfs∗5}
In Vitro Splicing Assay and In Silico Analysis
An in vitro splice assay was performed to test the effects of the
opsin interchange haplotypes as a result of combinations of SNP
variants associated with disease. The splicing patterns of two color-
normal wild-type opsin haplotypes LVAIS (L-) and MVAIA (M-)
were compared with three haplotypes encoding LIAVA, LVAVA, and
MIAVA that were associated with disease, and therefore presumed
loss of functional opsin (Supp. Table S1; Table 1). An analysis of
the resulting spliced cDNA products demonstrated that the wild-
type andmutant constructs produced differently spliced transcripts
(Table 1; Fig. 4).
The wild-type constructs produced a single product correspond-
ing to the correctly spliced cone opsin transcript. In contrast, LIAVA
produced a single smaller transcript due to exon 3 skipping (exon 2
spliced onto exon 4), as previously described [Ueyama et al., 2012].
Interestingly, LVAVA and MIAVA resulted in a different pattern of
aberrant splicing, with several transcripts being produced (Fig. 4).
Cloning and sequencing revealed a transcript with exon 3 skipping,
as established for the LIAVA haplotype, an additional aberrant tran-
script with partial exon 2 spliced on to intron 3, and a low level of
the correctly spliced cone opsin transcript (Fig. 4).
Given that all three disease-associated interchange haplotypes
tested resulted in aberrant splicing, pre-mRNA splicing prediction
programs were used to assess whether the SNPs could abolish or
generate splice donor, splice acceptor, exonic splice enhancer (ESE)
or exonic splice silencer (ESS) sites. The three interchange haplo-
types were not predicted to introduce any cryptic splice donor or
acceptor sites, or to abolish the normal exon 3 donor and acceptor
sites. RESCUE-ESE predicted that four ESEs are present in wild-
type OPN1LW sequence and nine in OPN1MW [Fairbrother et al.,
2002] (Supp. Fig. S6). Interestingly, the variant c.532A>G present in
all three interchange haplotypes resulted in loss of an ESE, whereas
the other variants in the haplotypes had no predicted effect (Supp.
Fig. S6). Similarly, FAS–ESS predicted that 10 ESSs are present in
OPN1LW and OPN1MW wild-type sequence [Wang et al., 2004].
The c.532A>G variant resulted in the generation of an additional
splice silencer at this site, whereas the other variants had no effect
(Supp. Fig. S6). This analysis predicted that the c.532A>G variant
present in all disease-associated haplotypes could have a major role
in the aberrant splicing observed in the in vitro splicing assay. The
effect of altering this single nucleotide was therefore investigated in
isolation in the color-normal wild-type L- and M-genes. The data
show that the c.532A>G variant on a wild-type haplotype is suffi-
cient, in isolation, to cause aberrant splicing (exon 3 skipping) in
both the L-and M-opsin genes (Fig. 4).
Discussion
This study describes detailed phenotypic and genetic findings of
one of the largest cohorts to date of patients harboringmutations in
the cone opsin gene array and expands our knowledge of the genetic
mechanisms and phenotypic variability.
There was considerable variation in the severity and progression
of disease in the cohort, with some evidence of genotype–phenotype
correlation. Subjects with LCR deletions and those harboring the
p.Cys203Arg variant were more likely to have nystagmus, poor vi-
sion, and severe cone system dysfunction. These patients generally
had normal fundus imaging and no evidence of progression with
age, the exception being some individuals with p.Cys203Arg muta-
tions who had evidence of retinal degeneration. Rod system involve-
ment varied with a young patient from each of these two patient
groups showing mild abnormalities of the scotopic dim flash (DA
0.01) and bright flash (DA 11.0) ERGs. It is noted that reduction in
bright flash ERG (Supp. Tables S2 and S3) could partly relate to a
loss of the dark-adapted cone system contribution, also absent in the
scotopic red flash ERGs (Supp. Fig. S2). However, the DA0.01 ERGs
are recorded to a dim flash, which is below cone system threshold
and is selective for the rod system.
In contrast, patients with exon 3 interchange haplotypes were less
likely to have nystagmus and had better VA, particularly below the
age of 40. The phenotype appeared age dependent, with patients
below the age of 40 having normal fundus appearance and imaging,
whereas all patients over the age of 40 years showed marked central
macular abnormalities on fundus examination, FAF, and SD-OCT,
with the exception of S25, who had incomplete imaging. All inter-
change haplotype patients had evidence of cone system dysfunction
with a tendency for flicker ERG amplitudes to be smaller with in-
creasing age (Supp. Fig. S4). Additionally, serial ERGs in two of
the oldest patients suggested progressive rod system dysfunction in
the advanced stages of disease. S-cone ERG amplitudes were ab-
normal in only one of the oldest patients. These findings suggest
that patients with LCR deletions are more likely to have a typical
BCM phenotype that is predominantly nonprogressive, although
progression has previously been reported in some cases with LCR
deletions [Fleischman and O’Donnell, 1981; Nathans et al., 1989;
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Figure 4. Disease-associatedexon3SNP interchangehaplotypes re-
sult in differential aberrant splicing. A: Agarose gel showing cone opsin
RT-PCR products resulting from in vitro splice analysis of five different
opsin haplotype minigenes: lanes 2–3 show color-normal haplotypes
LVAIS and MVAIA, lanes 4–6 show disease-associated haplotypes LI-
AVA, LVAVA, and MIAVA, respectively. LVAIS and MVAIA produce a
single product (transcript a) of 900 bp representing normally spliced
opsin. LIAVA produces a differently spliced transcript (transcript b) and
LVAVA and MIAVA have an apparent additional product (transcript c).
B: Further resolution of RT-PCR products for LVAVA and MIAVA reveal
that product c is in fact two transcripts (transcripts c and d).C: Sequenc-
ing revealed that transcripts a and d both represent normally spliced
cone opsin; transcript c, produced by LVAVA and MIAVA, is the result
of internal exon 2 splicing onto intronic 3 sequence, and transcript b
represents exon 3 skipping. D: Agarose gel showing cone opsin RT-PCR
products resulting from in vitro splice analysis of wild-type L- (LVAIS,
lane 3) compared with introduction of a single SNP, c. 532A>G, within
this haplotype (LVAVS, lane 4), and for wild-typeM- (MVAIA) cone opsin
(lane 5) compared with the same haplotype with the introduction of the
SNP c. 532A>G (lane 6). Lane 2 is a negative control. In contrast to
wild-type haplotypes, introduction of the SNP c.532A>G in both the L-
and M-gene results in two transcripts, the larger transcript is normally
spliced opsin (900 bp) and the smaller transcript (highlighted with an
asterix) is an aberrant transcript resulting from exon 3 skipping.
Ayyagari et al., 1999]. Patients with p.Cys203Arg missense variants
can also have a typical BCM phenotype or experience slow progres-
sion over time.
In our cohort, patients with exon 3 interchange haplotypes com-
monly had a progressively worsening phenotype, including visual
acuity reduction, with onset of macular atrophy after the age of 40
years, and electrophysiological evidence of progressive loss of cone
function with increasing rod involvement over time. These results
are in keeping with other reports showing that some patients with
exon 3 interchange haplotypes have more severe outer retinal at-
rophy than patients with p.Cys203Arg mutations, and that these
patients also report a progressive loss of visual function [Carroll
et al., 2012]. The interchange haplotype patients in the cohort, ex-
cept S26 (who harbors the LVAVA haplotype), all developed symp-
toms in their first decade. Importantly, high-resolution adaptive
optics imaging has shown differences in the cone mosaic in pa-
tients with p.Cys203Arg and exon 3 interchange haplotypes [Carroll
et al., 2009, 2012] as well as in carrier females with LCR deletions,
further highlighting the phenotypic differences of each mutation
category.
We observed three different exon 3 SNP interchange haplotypes
encoding LIAVA, LVAVA, and MIAVA that were associated with dis-
ease in our cohort. Four families had multigene arrays that com-
prised a third, common M-gene haplotype, MVVVA [Neitz et al.,
2004]. It is evident that both MIAVA and LVAVA result in aber-
rant pre-mRNA splicing in vitro that is different to that caused
by LIAVA. The LIAVA haplotype transcript resulting from exon 3
skipping is predicted to be degraded by nonsense-mediated decay
(NMD) or to result in a frameshift, producing a truncated protein
with a premature stop codon (p.Ile138Thrfs∗6). In comparison,
the MIAVA and LVAVA haplotypes both resulted in an additional
aberrant transcript that is also predicted to be degraded by NMD
or to produce an alternative frame-shifted truncated protein prod-
uct (p.Tyr118Serfs∗5). However, a residual level of normally spliced
opsin was also detected, atmuch lower levels than the aberrant tran-
scripts. It is plausible that these residual levels of correctly spliced
cone opsin in individuals with an LVAVA orMIAVA haplotype could
result in a population of cones that express some functional opsin.
Over time, the survival of these photoreceptor cells may be impaired
by the simultaneous expression of the aberrant transcripts or mu-
tant proteins, if expressed. Individuals with an LIAVA haplotype
may be predicted to have congenital disease and a more stable dis-
ease course. However, this study is limited by the relatively small
cohort size in each category and there is inherent difficulty in ex-
trapolating these data to draw conclusions on genotype–phenotype
correlation. Further detailed serial quantitative high-resolution reti-
nal imaging in larger cohorts of molecularly confirmed patients will
be necessary to establish the cellular phenotype associated with the
different classes of cone opsin mutations. Robust data on their nat-
ural history will help to identify which patients/genotype classes
may be potentially most amenable to novel interventions in the
future.
The c.532A>Gvariantwas common to all three disease-associated
interchange haplotypes. We have shown that c.532A>G alone can
cause aberrant pre-mRNA splicing in vitro, suggesting it contributes
tomis-splicing in all three haplotypes and that the other seven SNPs
in the haplotypes further modulate its functional outcome. The
minor allele “G” of c.532A>G (ref dbSNP rs145009674) has a re-
ported minor allele frequency of 2.2% in both the 1000 Genomes
Dataset and the NHLBI Exome Sequencing Project (ESP). How-
ever, these data do not take into account the position or num-
ber of L- or M-genes in the array. It would be interesting to
investigate the frequency, context, and position of this SNP in
red/green color blind subjects, who account for up to 8% of males
and 0.5% of females among populations of Northern European
origin [Deeb and Motulsky, 2011], and in color vision normal
subjects.
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